Control of plasma nitric oxide bioactivity by perfluorocarbons: Physiological mechanisms and clinical implications

Circulation

Volumn 110, Issue 23, 2004, Pages 3573-3580

  Rafikova, Olga ^a   Sokolova, Elena ^a   Rafikov, Ruslan ^a   Nudler, Evgeny ^a,b  

^a NEW YORK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Blood pressure; Hemodynamics; Nitric oxide; Oxygen fluorocarbons

Indexed keywords

CYSTEINE; FLUOROCARBON; GLUTATHIONE; NITRIC OXIDE; OXYGEN; S NITROSOTHIOL;

ABSORPTION; ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; CATALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTROCHEMISTRY; EMULSION; HEMODYNAMICS; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; MICELLE; NITROSATION; NONHUMAN; OXIDATION; PHYSIOLOGY; PRIORITY JOURNAL; RAT; TRANSPORT KINETICS;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD PRESSURE; BLOOD SUBSTITUTES; ELECTROCHEMISTRY; FLUOROCARBONS; INJECTIONS, INTRAVENOUS; MALE; MICELLES; NITRIC OXIDE; OXIDATION-REDUCTION; RATS; RATS, INBRED WKY; S-NITROSOTHIOLS;

EID: 10044290667     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000148782.37563.F8     Document Type: Article

References (46)

1. Moncada S. Nitric oxide in the vasculature: physiology and pathophysiology. Ann N Y Acad Sci. 1997;811:60-67.
2. Hanafy KA, Krumenacker JS, Murad F. NO, nitrotyrosine, and cyclic GMP in signal transduction. Med Sci Monit. 2001;7:801-819.
3. Ignarro LJ, Lippton H, Edwards JC, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside, and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981;218:739-749.
4. Simon DI, Stamler JS, Jaraki O, et al. Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arteriosder Thromb. 1993;13:791-799.
5. Scharfstein JS, Keaney JF Jr, Slivka A, et al. In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J Clin Invest. 1994;94:1432-1439.
6. Jia L, Bonaventura C, Bonaventura J, et al. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature. 1996; 380:221-226.
7. Stamler JS, Lamas S, Fang FC. Nitrosylation: the prototypic redox-based signaling mechanism. Cell. 2001;106:675-683.
8. Singh RJ, Hogg N, Joseph J, et al. Mechanism of nitric oxide release from S-nitrosothiols. J Biol Chem. 1996;271:18596-18603.
9. Kashiba-Iwatsuki M, Kitoh K, Kasahara E, et al. Ascorbic acid and reducing agents regulate the fates and functions of S-nitrosothiols. J Biochem. 1997;122:1208-1214.
10. Jourd'heuil D, Hallen K, Feelisch M, et al. Dynamic state of S-nitrosothiols in human plasma and whole blood. Free Radic Biol Med. 2000;28:409-417.
11. Rassaf T, Kleinbongard P, Preik M, et al. Plasma nitrosothiols contribute to the systemic vasodilator effects of intravenously applied NO: experimental and clinical study on the fate of NO in human blood. Circ Res. 2002;91:470-477.
12. Hogg N. Biological chemistry and clinical potential of S-nitrosothiols. Free Radic Biol Med. 2000;28:1478-1486.
13. Al-Sa'doni H, Ferro A. S-Nitrosothiols: a class of nitric oxide-donor drugs. Clin Sci (Lond). 2000;98:507-520.
14. Richardson G, Benjamin N. Potential therapeutic uses for S-nitrosothiols. Clin Sci (Lond). 2002;102:99-105.
15. Gladwin MT, Lancaster JR Jr, Freeman BA, et al. Nitric oxide's reactions with hemoglobin: a view through the SNO-storm. Nat Med. 2003;9:496-500.
16. Joshi MS, Ferguson TB Jr, Han TH, et al. Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditions. Proc Natl Acad Sci U S A. 2002;99:10341-10346.
17. 2 reaction. Chem Res Toxicol. 1994;7:519-525.
18. Lewis RS, Deen WM. Kinetics of the reaction of nitric oxide with oxygen in aqueous solutions. Chem Res Toxicol. 1994;7:568-574.
19. 2 within the hydrophobic interior of biological membranes. Proc Natl Acad Sci U S A. 1998;95:2175-2179.
20. Nedospasov A, Rafikov R, Beda N, et al. An autocatalytic mechanism of protein nitrosylation. Proc Natl Acad Sci U S A. 2000;97:13543-13548.
21. Rafikova O, Rafikov R, Nudler E. Catalysis of S-nitrosothiols formation by serum albumin: the mechanism and implication in vascular control. Proc Natl Acad Sci U S A. 2002;99:5913-5918.
22. Lowe KC. Perfluorinated blood substitutes and artificial oxygen carriers. Blood Rev. 1999;13:171-184.
23. Lane TA. Perfluorochemical-based artificial oxygen carrying red cell substitutes. Transfus Sci. 1995;16:19-31.
24. Spahn DR. Blood substitutes: artificial oxygen carriers: perfluorocarbon emulsions. Crit Care. 1999;3:93-97.
25. Velury S, Howell SB. Measurement of plasma thiols after derivatization with monobromobimane. J Chromatogr. 1988;424:141-146.
26. st Century. Banks RE, Lowe KC, eds. Shrewsbury, UK: Rapra; 1994.
27. Dejam A, Hunter CJ, Schechter AN, et al. Emerging role of nitrite in human biology. Blood Cells Mol Dis. 2004;32:423-429.
28. Godber BL, Doel JJ, Sapkota GP, et al. Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase. J Biol Chem. 2000;275:7757-7763.
29. Cosby K, Partovi KS, Crawford JH, et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med. 2003;9:1498-1505.
30. Zweier JL, Samouilov A, Kuppusamy P. Non-enzymatic nitric oxide synthesis in biological systems. Biochim Biophys Acta. 1999;1411:250-262.
31. Gladwin MT, Shelhamer JH, Schechter AN, et al. Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc Natl Acad Sci U S A. 2000;97:11482-11487.
32. Rassaf T, Feelisch M, Keim M. Circulating NO pool: assessment of nitrite and nitroso species in blood and tissues. Free Radic Biol Med. 2004;36:413-422.
33. Goldman RK, et al. Nitrosothiol quantification in human plasma. Anal Biochem. 1998;259:98-103.
34. Giustarini D, Milzani A, Colombo R, et al. Nitric oxide, S-nitrosothiols and hemoglobin: is methodology the key? Trends Pharm Sci. 2004;25:311-316.
35. Ookhtens M, Mittur AV, Erhart NA. Changes in plasma glutathione concentrations, turnover, and disposal in developing rats. Am J Physiol. 1994;266:979-988.
36. Faithfull NS, King CE, Cain SM. Peripheral vascular responses to fluorocarbon administration. Microvasc Res. 1987;33:183-193.
37. Mattrey RF, Hilpert PL, Long CD, et al. Hemodynamic effects of intravenous lecithin-based perfluorocarbon emulsions in dogs. Crit Care Med. 1989;17:652-656.
38. 2 transport in dogs. J Appl Physiol. 1995;79:1777-1786.
39. Lowe KC. Second-generation perfluorocarbon emulsion blood substitutes. Artif Cells Blood Substit Immobil Biotechnol. 2000;28:25-38.
40. Heard SO, Puyana JC. The anti-inflammatory effects of perfluorocarbons: let's get physical. Crit Care Med. 2000;28:1241-1242.
41. Gaston B, Sears S, Woods J, et al. Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet. 1998;351:1317-1319.
42. Foster MW, McMahon TJ, Stamler JS. S-nitrosylation in health and disease. Trends Mol Med. 2003;9:160-168.
43. Sehajpal PK, Basu A, Ogiste JS, et al. Reversible S-nitrosation and inhibition of HIV-1 protease. Biochemistry. 1999;38:13407-13413.
44. De Groote MA, Testerman T, Xu Y, et al. Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. Science. 1996;272:414-417.
45. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996;271:1424-1437.
46. Nakazawa H, Fukuyama N, Takizawa S, et al. Nitrotyrosine formation and its role in various pathological conditions. Free Radic Res. 2000;33:771-784.